β-lapachone, a quinone isolated from Tabebuia avellanedae, induces apoptosis in HepG2 hepatoma cell line through induction of Bax and activation of caspase

Journal of Medicinal Food

Volumn 9, Issue 2, 2006, Pages 161-168

  Woo, Hyun Joo ^a   Park, Kun Young ^b   Rhu, Chung Ho ^d   Lee, Won Ho ^b   Choi, Byung Tae ^a   Kim, Gi Young ^e   Park, Yeong Min ^c   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

^b Pusan National University   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

^d Gyeongsang National University   (South Korea)

^e Jeju National University   (South Korea)

Author keywords

lapachone; Apoptosis; Bcl 2 family; Caspase; HepG2

Indexed keywords

BETA LAPACHONE; CASPASE; CASPASE 3; CASPASE 9; DNA FRAGMENT; DNA TOPOISOMERASE INHIBITOR; FAS ANTIGEN; FAS LIGAND; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; QUINONE DERIVATIVE; TABEBUIA AVELLANEDAE EXTRACT; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; BARK; CANCER CELL CULTURE; CANCER GROWTH; CANCER PREVENTION; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG ISOLATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTH AMERICA; TABEBUIA; TABEBUIA AVELLANEDAE;

ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASE 9; CASPASES; CELL DIVISION; CELL LINE, TUMOR; DNA FRAGMENTATION; ENZYME ACTIVATION; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; NAPHTHOQUINONES; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TABEBUIA; TUMOR NECROSIS FACTORS;

TABEBUIA AVELLANEDAE;

EID: 33745849783     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.9.161     Document Type: Article

References (35)

1. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl):S4-S66.
2. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr: International trends and patterns of primary liver cancer. Int J Cancer 2001;94:290-296.
3. Sheu JC: Molecular mechanism of hepatocarcinogenesis. J Gastroenterol Hepatol 1997;12(Suppl):S309-S313.
4. Robertson JD, Orrenius S: Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol 2000;30: 609-627.
5. Walker PR, Sikorska M: New aspects of the mechanism of DNA fragmentation in apoptosis. Biochem Cell Biol 1997;75:287-299.
6. Hengartner MO: The biochemistry of apoptosis. Nature 2000;407: 770-776.
7. Herr I, Debatin KM: Cellular stress response and apoptosis in cancer therapy. Blood 2001;98:2603-2614.
8. Schaffner-Sabba K, Schmidt-Ruppin KH, Wehrli W, Schuerch AR, Wasley JW: β-Lapachone: synthesis of derivatives and activities in tumor models. J Med Chem 1984;27:990-994.
9. Boorstein RJ, Pardee AB: β-Lapachone greatly enhances MMS lethality to human fibroblasts. Biochem Biophys Res Commun 1984;118:828-834.
10. Boothman DA, Trask DK, Pardee AB: Inhibition of potentially lethal DNA damage repair in human tumor cells by β-lapachone, an activator of topoisomerase I. Cancer Res 1989;49:605-612.
11. Frydman B, Marton LJ, Sun JS, Neder K, Witiak DT, Liu AA, Wang HM, Mao Y, Wu HY, Sanders MM, Liu LF: Induction of DNA topoisomerase II-mediated DNA cleavage by β-lapachone and related naphthoquinones. Cancer Res 1997;57:620-627.
12. Li CJ, Averboukh L, Pardee AB: β-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. J Biol Chem 1993;268:22463-22468.
13. Li CJ, Wang C, Pardee AB: Induction of apoptosis by β-lapachone in human prostate cancer cells. Cancer Res 1995;55:3712-3715.
14. Pardee AB, Li YZ, Li C J: Cancer therapy with β-lapachone. Curr Cancer Drug Targets 2002;2:227-242.
15. Lopes JN, Cruz FS, Docampo R, Vasconcellos ME, Sampaio MC, Pinto AV, Gilbert B: In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2-naphthoquinone derivatives against Trypanosoma cruzi. Ann Trop Med Parasitol 1978;72:523-531.
16. Goijman SG, Stoppani AO: Effects of β-lapachone, a peroxide-generating quinone, on macromolecule synthesis and degradation in Trypanosoma cruzi. Arch Biochem Biophys 1985;240:273-280.
17. Guiraud P, Steiman R, Campos-Takaki GM, Seigle-Murandi F, Simeon de Buochberg M: Comparison of antibacterial and antifungal activities of lapachol and β-lapachone. Planta Med 1994;60:373-374.
18. Cruz FS, Docampo R, Boveris A: Generation of superoxide anions and hydrogen peroxide from β-lapachone in bacteria. Antimicrob Agents Chemother 1978;14:630-633.
19. Docampo R, Cruz FS, Boveris A, Muniz RP, Esquivel DM: β-Lapachone enhancement of lipid peroxidation and superoxide anion and hydrogen peroxide formation by sarcoma 180 ascites tumor cells. Biochem Pharmacol 1979;28:723-728.
20. Choi YH, Kong KR, Kim YA, Jung KO, Kil JH, Rhee SH, Park KY: Induction of Bax and activation of caspases during β-sitosterol-mediated apoptosis in human colon cancer cells. Int J Oncol 2003;23:1657-1661.
21. Choi YH, Lee SJ, Nguyen P, Jang JS, Lee J, Wu ML, Takano E, Henkart PA, Trepel JB: Regulation of cyclin D1 by calpain protease. J Biol Chem 1997;272:28479-28484.
22. Planchon SM, Pink JJ, Tagliarino C, Bornmann WG, Varnes ME, Boothman DA: β-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3. Exp Cell Res 2001;267:95-106.
23. Planchon SM, Wuerzberger S, Frydman B, Witiak DT, Hutson P, Church DR, Wilding G, Boothman DA: β-Lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response. Cancer Res 1995;55:3706-3711.
24. Choi YH, Kang HS, Yoo MA: Suppression of human prostate cancer cell growth by β-lapachone via down-regulation of pRB phosphorylation and induction of Cdk inhibitor p21 (WAF1/ CIP1). J Biochem Mol Biol 2003;36:223-229.
25. Choi BT, Cheong JH, Choi YH: β-Lapachone-induced apoptosis is associated with activation of caspase-3 and inactivation of NF-kB in human colon cancer HCT-116 cells. Anticancer Drugs 2003;14:845-850.
26. Daniel PT, Schulze-Osthoff K, Belka C, Guner D: Guardians of cell death: the Bcl-2 family proteins. Essays Biochem 2003;39: 73-88.
27. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998;281:1312-1316.
28. Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B, Borner C: Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 1998;391:496-499.
29. Stennicke HR, Salvesen GS: Properties of the caspases. Biochim Biophys Acta 1998;1387:17-31.
30. Earnshaw WC, Martins LM, Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999;68:383-424.
31. Deveraux QL, Reed JC: IAP family proteins-suppressors of apoptosis. Genes Dev 1999;13:239-252.
32. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC: The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997;16:6914-6925.
33. Nagata S, Golstein P: The Fas death factor. Science 1996;267: 1449-1456.
34. Dockrell DH: The multiple roles of Fas ligand in the pathogenesis of infectious diseases. Clin Microbiol Infect 2003;9:766-779.
35. Jiang C, Yang YF, Cheng SH: Fas ligand gene therapy for vascular intimal hyperplasia. Curr Gene Ther 2004;4:33-39.